1 00:00:00,800 --> 00:00:05,160 Speaker 1: Andrew Dickens ers five point twenty one on supermarkets. Craig 2 00:00:05,200 --> 00:00:08,480 Speaker 1: records a warehouse system to service the supermarkets will cost 3 00:00:08,480 --> 00:00:10,360 Speaker 1: a billion to set up. That's fair. And you heard 4 00:00:10,720 --> 00:00:12,920 Speaker 1: tech say they'd have to have one hundred and forty shops. 5 00:00:12,920 --> 00:00:15,960 Speaker 1: That's a lot. Now. One of the largest farmer companies 6 00:00:16,000 --> 00:00:18,079 Speaker 1: in the world is being taken to court in New Zealand. 7 00:00:18,400 --> 00:00:21,959 Speaker 1: A class action filed today says Johnson and Johnson have 8 00:00:22,239 --> 00:00:26,079 Speaker 1: deceived Kiwi customers for years by selling them cold and 9 00:00:26,079 --> 00:00:30,560 Speaker 1: flu medication that just doesn't work. In question is the 10 00:00:30,760 --> 00:00:38,080 Speaker 1: ingredient fennef h here we go, fenelfrine fenlefrine that is 11 00:00:38,120 --> 00:00:41,440 Speaker 1: in the Kodril and in the Suda head. J G. A. 12 00:00:41,600 --> 00:00:45,760 Speaker 1: Sadler Director Rebecca Jankowska is the lawyer behind the class action, 13 00:00:45,800 --> 00:00:50,440 Speaker 1: and she joins me, now, hello, Rebecca, Hello, So do 14 00:00:50,520 --> 00:00:52,280 Speaker 1: they work? Don't they work? They don't work? You reckon? 15 00:00:52,280 --> 00:00:53,080 Speaker 1: They don't work. 16 00:00:54,520 --> 00:00:59,080 Speaker 2: Well. Our class action that we've filed today alleges that 17 00:00:59,600 --> 00:01:03,680 Speaker 2: the Qadrill, Pseudofed, and Benadryl range of cold and flu 18 00:01:03,720 --> 00:01:08,440 Speaker 2: products that contain fenlefrin are ineffective at treating congestion and 19 00:01:08,720 --> 00:01:13,840 Speaker 2: other symptoms of colds and flu. Now these are symptoms 20 00:01:13,880 --> 00:01:20,160 Speaker 2: that these products were marketed to treat. Now, the evidence 21 00:01:20,240 --> 00:01:24,160 Speaker 2: in respect of the efficacy of fenlefrin is pretty overwhelming. 22 00:01:26,160 --> 00:01:29,880 Speaker 2: The studies concerning fenlefren when taken orally, date back to 23 00:01:29,920 --> 00:01:33,880 Speaker 2: the sixties and seventies, and they show that fenlefrin is 24 00:01:33,959 --> 00:01:37,839 Speaker 2: no more effective than a placebo at treating these symptoms. 25 00:01:37,880 --> 00:01:42,080 Speaker 2: So our class action aims to recover the amount spent 26 00:01:42,160 --> 00:01:45,000 Speaker 2: by Kiwis on these products for the last twenty years. 27 00:01:45,240 --> 00:01:49,680 Speaker 1: Has any other jurisdiction had seen such a claim, such 28 00:01:49,680 --> 00:01:52,240 Speaker 1: an action. If you're saying that the evidence, the scientific 29 00:01:52,240 --> 00:01:55,080 Speaker 1: evidence that as an effective goes back so far, surely 30 00:01:55,120 --> 00:01:55,960 Speaker 1: another country has. 31 00:01:55,880 --> 00:01:59,400 Speaker 2: Done it well. We filed at our firm filed a 32 00:01:59,520 --> 00:02:03,480 Speaker 2: claim Australia in December, so we have a class action 33 00:02:03,560 --> 00:02:07,480 Speaker 2: on foot there. A Canadian firm file the class action 34 00:02:07,560 --> 00:02:10,880 Speaker 2: about twelve months ago in Canada and so that claim 35 00:02:10,960 --> 00:02:15,440 Speaker 2: is proceeding through the usual steps. And there's also quite 36 00:02:15,560 --> 00:02:17,840 Speaker 2: quite a number of claims on foot in America in 37 00:02:17,880 --> 00:02:20,360 Speaker 2: respect of these products. So I think we're going to 38 00:02:20,400 --> 00:02:23,600 Speaker 2: see further litigation in other countries. But as it stands, 39 00:02:23,720 --> 00:02:27,560 Speaker 2: there's there's already a few countries where where cases are underway. 40 00:02:27,160 --> 00:02:29,720 Speaker 1: But you don't have any precedent yet. 41 00:02:29,919 --> 00:02:32,440 Speaker 2: No no cases have yet been determined. Everything is still 42 00:02:32,440 --> 00:02:36,240 Speaker 2: in its infancy. And that's because you know this, this 43 00:02:36,320 --> 00:02:41,520 Speaker 2: wave of litigation has has been sparked by the Food 44 00:02:41,560 --> 00:02:45,000 Speaker 2: and Drug Administration's review. Now they're the regulatory body in 45 00:02:45,040 --> 00:02:49,160 Speaker 2: the United States, and in about September of twenty twenty three, 46 00:02:49,560 --> 00:02:51,920 Speaker 2: the FDA announced the results of a review that they 47 00:02:51,919 --> 00:02:55,680 Speaker 2: had carried out into the efficacy of fenlefrin when taken orally, 48 00:02:56,120 --> 00:02:59,960 Speaker 2: and that review showed that fenn lefren simply wasn't effective 49 00:03:00,200 --> 00:03:04,800 Speaker 2: in the tablet or the liquid form. So as a 50 00:03:04,800 --> 00:03:08,000 Speaker 2: result of that review, we started investigating and have brought 51 00:03:08,040 --> 00:03:09,840 Speaker 2: the two class actions that we have. 52 00:03:10,080 --> 00:03:12,240 Speaker 1: Finally, if anyone wants to join your class action, how 53 00:03:12,240 --> 00:03:13,239 Speaker 1: can they get in touch with it. 54 00:03:15,160 --> 00:03:17,680 Speaker 2: We encourage every New Zealander who's bought one of these products, 55 00:03:17,680 --> 00:03:20,079 Speaker 2: whether it's one packet or one hundred packets, to register 56 00:03:20,720 --> 00:03:22,840 Speaker 2: visit our website that we've set up for this case, 57 00:03:22,880 --> 00:03:26,920 Speaker 2: which is Coldenflu Classaction dot co dot NZ. There's no 58 00:03:26,960 --> 00:03:29,239 Speaker 2: need to have receipts or proof of purchase We simply 59 00:03:29,280 --> 00:03:32,200 Speaker 2: ask you to tell us on the form how many 60 00:03:32,240 --> 00:03:35,080 Speaker 2: packets you think you've bought over what period, and you'll 61 00:03:35,120 --> 00:03:35,680 Speaker 2: be registered. 62 00:03:36,160 --> 00:03:39,640 Speaker 1: Rebecca jen kowskis from j GA Sailer. I thank you 63 00:03:39,640 --> 00:03:40,680 Speaker 1: so much for your time today. 64 00:03:41,360 --> 00:03:44,560 Speaker 2: For more from Hither Duplessy, Allen Drive, listen live to 65 00:03:44,640 --> 00:03:47,680 Speaker 2: news talks it'd be from four pm weekdays, or follow 66 00:03:47,680 --> 00:03:49,480 Speaker 2: the podcast on iHeartRadio.